Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Olbrecht

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Value in Health Regional Issues|February 19, 2019
Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish ChildrenAlen Marijam, Jan Olbrecht, Alev Ozakay, et al.
Expert Review of Vaccines|March 21, 2020
Ten years of experience with the pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccine (<i>Synflorix</i>) in childrenNicolas Lecrenier, Alen Marijam, Jan Olbrecht, et al.
Value in Health Regional Issues|April 13, 2021
Constrained Optimization for Pneumococcal Vaccination in BrazilJan Olbrecht, Jorge A Gomez, Laure-Anne Van Bellinghen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Value in Health Regional Issues|February 19, 2019
Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish ChildrenAlen Marijam, Jan Olbrecht, Alev Ozakay, et al.
Expert Review of Vaccines|March 21, 2020
Ten years of experience with the pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccine (<i>Synflorix</i>) in childrenNicolas Lecrenier, Alen Marijam, Jan Olbrecht, et al.
Value in Health Regional Issues|April 13, 2021
Constrained Optimization for Pneumococcal Vaccination in BrazilJan Olbrecht, Jorge A Gomez, Laure-Anne Van Bellinghen, et al.
Pageof 1